Drug approval isn't the finish line; it's where the real questions begin. 🔥 ⭐️#Registries & real-world data fill the gaps RCTs leave: long-term safety & real world more complex patients. ⭐️Can umbrella, basket & platform trials speed up #GN research?! 👇 📄 link.springer.com/article/10… @poyanmehr @Tripti_neph @AlJurdi @BetterCallSeeth @d_r_waguespack @AKronbichler #Nephrology #RareKidneyDisease #RKD

Lunch and more IgAN w/ @Srmanday & @AlJurdi #GlomConHawaii

Excited to be a part of this!

Great renal grand rounds @MGBKidneys Ritu Seethapathy discussing rare entity of podocyte infolding glomerulopathy(PIG) after kidney #transplantation in patient w/ lupus. PIG is a morphologic manifestation of chronic podocyte injury &interferon-driven immune dysregulation @AlJurdi

Thrilled to see our #GlomConHawaii meeting report officially published in Rare Kidney Disease! Proud of the hard work put in alongside amazing colleagues! Looking forward to seeing what #GlomCon2026 has in store! 🌺☀️🌊

Every vote counts! All eligible TTS members should vote here before the elections close on May 11. tts.org/148-tts/tts-members-…

Officially kicking off #GlomConHawaii 2026. Aug 3-7 at Hyatt Regency Maui. The faculty this year includes Ali Gharavi, @hjanders_hans , @PRomagnani , Martin Pollak, @VladoPerkovic , Michael Walsh, @GlassockJ , @fervenzaf , @SethiRenalPath , @Nester1Carla and many others — global thought leaders across every glomerular disease. Registration open: glomconhawaii.org #Nephrology #GlomConHawaii

🚨 NEW tool available: NephroVax is a free clinical decision support tool designed specifically for nephrologists and healthcare providers managing patients on complement inhibitor therapies. Based on a patient's age and prior vaccination history (or lack thereof), it provides a detailed breakdown of required vaccines and their schedules. The guidance is based on ACIP recommendations and publicly available CDC publications. Keep in mind that local and regional requirements may vary by area. Always cross-check with the latest CDC guidelines, FDA-approved vaccine labels, and your local health authorities. Download for free at Google Play and Apple App Store. Or access it via web at 👉 nephrovax.org/ 👉apps.apple.com/us/app/nephro… 👉 play.google.com/store/apps/d…

We’re very excited to be hosting the first Glomerular Disease Conference in Boston on May 30th! Join us to learn what’s new in glomerular diseases from world-class experts. In-person and virtual options available. Fellows/trainees can attend for free. DM for details.

Join us on May 30th for GLOMBoston 2026! 🔬This 1-day, live conference focuses on the understanding & management of glomerular disease 💬Learn from expert lectures & interactive case discussions REGISTER TODAY: cpd.partners.org/content/mgb… @BetterCallSeeth @AlJurdi @MGBKidneys

GlomCon Hawaii 2026 – August 3–7, Maui, Hawaii Advance glomerular disease expertise through expert sessions, interactive case discussions, and evidence-based treatment panels for clinicians and researchers. ✒️Register here: bit.ly/GlomConHawaii2026Regi… #Maui #GlomConHawaii2026

Join GlomCon this Sunday Tissue-based Molecular Diagnostics in Kidney Transplantation by Dr. Gaurav Gupta ID: 817 4374 4653 Passcode: 202122 Sign up 👉🏻bit.ly/signup-glomcon #GlomCon #Glomcon

🚨 We are pleased to announce the upcoming launch of GlomCon’s Rare Kidney Disease Journal, a new peer-reviewed journal developed in partnership with @SpringerNature. This journal will serve as a global platform dedicated to advancing research, clinical practice, and innovation in rare and complex kidney diseases.

Huge thank you to our incredible faculty, attendees, sponsors, and GlomCon instructors for making #GlomConHawaii conference a success! 🌟 Together, our community can achieve so much; this is truly an exciting time for the #Nephrology field. We deeply appreciate and value your partnership. Hope to see you all next year, in Maui August 2-7 ⭐️ Mahalo!! 🌺 #Nephrology #MedicalEducation #KidneyHealth #HealthcareCommunity #Gratitude #GlomerularDisease #Collaboration

The Podocytopathies Panel heating up 🔥 #GlomConHawaii @fervenzafernan1 @GlassockJ @AlJurdi @Dr_KeishaGibson @rheault_m @AstridWeins @d_r_waguespack

Excellent case-based discussion on #Podocytopathies 🐙 today!! @AstridWeins @PRomagnani @d_r_waguespack @fervenzafernan1 @GlassockJ Dr. Keisha Gibson and Dr. Michelle Rheault @AlJurdi the best! #GlomConHawaii2025 🌺 @GlomCon

The art of managing IgA Nephropathy: clinical trials, pathology, and real-world cases with an all-star panel at #GlomConHawaii For those following the trials landscape, here’s a recent overview: kidneymedicinejournal.org/ar…

Kicking off #glomconhawaii with a stellar panel: Discussion on clinical endpoints in RCTs! Dr. Nestor @uiowa Dr. Anders - LMU Munich Dr. Radhakrishnan @Columbia Dr. Walsh @McMasterU @GlomCon

Now let’s talk about treatment effect, sample size, and statistical analysis plan with Dr. Michael Walsh @lastwalsh and this great panel of experts 🧮 #GlomConHawaii2025 🌺 #GlomConHawai #GlomCon #RADIANT program

Excellent talk on effect size and sample size estimation for clinical trials by Dr. Michael Walsh at @GlomCon #GlomConHawaii